GABRIEL LEUNG Insider Trading $OSIP OSI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GABRIEL LEUNG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GABRIEL LEUNG. GABRIEL LEUNG is EVP & Pres. Pharma. Business in OSI PHARMACEUTICALS INC ($OSIP) and Exec. VP, Pres., (OSI) Onc. in OSI PHARMACEUTICALS INC ($OSIP).
GABRIEL LEUNG in OSI PHARMACEUTICALS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of GABRIEL LEUNG: EVP & Pres. Pharma. Business, Exec. VP, Pres., (OSI) Onc.
Holdings: 38,324 shares
Latest Transaction: Mar 03 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GABRIEL LEUNG in OSI PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | M | 30.74 | 18,472 | 567,829 | 10,000 | |
| Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | M | 23.85 | 24,761 | 590,550 | 1,000 | |
| Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Sell | S | 55.37 | 43,233 | 2,393,811 | 38,324 | 81.6 K to 38.3 K (-53.01 %) |
| Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Buy | M | 30.74 | 18,472 | 567,829 | 81,557 | 63.1 K to 81.6 K (+29.28 %) |
| Mar 03 2010 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Buy | M | 23.85 | 24,761 | 590,550 | 63,085 | 38.3 K to 63.1 K (+64.61 %) |
| Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Option Exercise | A | 35.40 | 20,000 | 708,000 | 20,000 | |
| Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 32.89 | 926 | 30,456 | 38,324 | 39.3 K to 38.3 K (-2.36 %) |
| Dec 18 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Grant | A | 0.00 | 6,700 | 0 | 39,250 | 32.6 K to 39.3 K (+20.58 %) |
| Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 34.75 | 795 | 27,626 | 32,550 | 33.3 K to 32.6 K (-2.38 %) |
| Dec 15 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 34.75 | 567 | 19,703 | 33,345 | 33.9 K to 33.3 K (-1.67 %) |
| Jul 16 2009 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | EVP & Pres. Pharma. ... | Payment of Exercise | F | 30.38 | 628 | 19,079 | 33,912 | 34.5 K to 33.9 K (-1.82 %) |
| Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 33.62 | 48,000 | 1,613,760 | 48,000 | |
| Dec 18 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 7,800 | 0 | 34,540 | 26.7 K to 34.5 K (+29.17 %) |
| Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 33.39 | 734 | 24,508 | 26,740 | 27.5 K to 26.7 K (-2.67 %) |
| Dec 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 33.39 | 657 | 21,937 | 27,474 | 28.1 K to 27.5 K (-2.34 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 15,000 | 357,750 | 112,500 | |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.41 | 300 | 16,023 | 28,131 | 28.4 K to 28.1 K (-1.06 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.40 | 300 | 16,020 | 28,431 | 28.7 K to 28.4 K (-1.04 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.29 | 500 | 26,645 | 28,731 | 29.2 K to 28.7 K (-1.71 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.26 | 900 | 47,934 | 29,231 | 30.1 K to 29.2 K (-2.99 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.20 | 1,100 | 58,520 | 30,131 | 31.2 K to 30.1 K (-3.52 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.24 | 530 | 28,217 | 31,231 | 31.8 K to 31.2 K (-1.67 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.22 | 1,200 | 63,864 | 31,761 | 33 K to 31.8 K (-3.64 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.21 | 600 | 31,926 | 32,961 | 33.6 K to 33 K (-1.79 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.18 | 900 | 47,862 | 33,561 | 34.5 K to 33.6 K (-2.61 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.23 | 285 | 15,171 | 34,461 | 34.7 K to 34.5 K (-0.82 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.25 | 285 | 15,176 | 34,746 | 35 K to 34.7 K (-0.81 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.04 | 300 | 15,912 | 35,031 | 35.3 K to 35 K (-0.85 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.02 | 600 | 31,812 | 35,331 | 35.9 K to 35.3 K (-1.67 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 53.00 | 700 | 37,100 | 35,931 | 36.6 K to 35.9 K (-1.91 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.75 | 400 | 21,100 | 36,631 | 37 K to 36.6 K (-1.08 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.59 | 500 | 26,295 | 37,031 | 37.5 K to 37 K (-1.33 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.87 | 1,200 | 63,444 | 37,531 | 38.7 K to 37.5 K (-3.10 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.50 | 1,400 | 73,500 | 38,731 | 40.1 K to 38.7 K (-3.49 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.53 | 300 | 15,759 | 40,131 | 40.4 K to 40.1 K (-0.74 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.56 | 900 | 47,304 | 40,431 | 41.3 K to 40.4 K (-2.18 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.62 | 300 | 15,786 | 41,331 | 41.6 K to 41.3 K (-0.72 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.72 | 300 | 15,816 | 41,631 | 41.9 K to 41.6 K (-0.72 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.73 | 500 | 26,365 | 41,931 | 42.4 K to 41.9 K (-1.18 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.67 | 300 | 15,801 | 42,431 | 42.7 K to 42.4 K (-0.70 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 52.52 | 400 | 21,008 | 42,731 | 43.1 K to 42.7 K (-0.93 %) |
| Aug 01 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 15,000 | 357,750 | 43,131 | 28.1 K to 43.1 K (+53.32 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 9,941 | 237,093 | 127,500 | |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.19 | 341 | 17,115 | 28,131 | 28.5 K to 28.1 K (-1.20 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.17 | 1,200 | 60,204 | 28,472 | 29.7 K to 28.5 K (-4.04 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.01 | 1,668 | 83,417 | 29,672 | 31.3 K to 29.7 K (-5.32 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.00 | 5,732 | 286,600 | 31,340 | 37.1 K to 31.3 K (-15.46 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.02 | 300 | 15,006 | 37,072 | 37.4 K to 37.1 K (-0.80 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.05 | 200 | 10,010 | 37,372 | 37.6 K to 37.4 K (-0.53 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.04 | 500 | 25,020 | 37,572 | 38.1 K to 37.6 K (-1.31 %) |
| Jul 24 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 9,941 | 237,093 | 38,072 | 28.1 K to 38.1 K (+35.34 %) |
| Jul 22 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 59 | 1,407 | 137,441 | |
| Jul 22 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 50.00 | 59 | 2,950 | 28,131 | 28.2 K to 28.1 K (-0.21 %) |
| Jul 22 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 59 | 1,407 | 28,190 | 28.1 K to 28.2 K (+0.21 %) |
| Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 5,000 | 119,250 | 137,500 | |
| Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 47.50 | 5,000 | 237,500 | 28,131 | 33.1 K to 28.1 K (-15.09 %) |
| Jul 17 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 5,000 | 119,250 | 33,131 | 28.1 K to 33.1 K (+17.77 %) |
| Jul 16 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 44.72 | 566 | 25,312 | 28,131 | 28.7 K to 28.1 K (-1.97 %) |
| Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | M | 23.85 | 5,000 | 119,250 | 142,500 | |
| Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Sell | S | 45.00 | 5,000 | 225,000 | 28,697 | 33.7 K to 28.7 K (-14.84 %) |
| Jul 11 2008 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Buy | M | 23.85 | 5,000 | 119,250 | 33,697 | 28.7 K to 33.7 K (+17.42 %) |
| Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 47.29 | 18,000 | 851,220 | 18,000 | |
| Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 47.79 | 566 | 27,049 | 28,697 | 29.3 K to 28.7 K (-1.93 %) |
| Dec 14 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 6,000 | 0 | 29,263 | 23.3 K to 29.3 K (+25.79 %) |
| Jul 18 2007 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Payment of Exercise | F | 33.71 | 566 | 19,080 | 23,263 | 23.8 K to 23.3 K (-2.38 %) |
| Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 37.74 | 20,000 | 754,800 | 20,000 | |
| Dec 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 6,700 | 0 | 23,829 | 17.1 K to 23.8 K (+39.11 %) |
| Jul 18 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Grant | A | 0.00 | 6,700 | 0 | 17,129 | 10.4 K to 17.1 K (+64.24 %) |
| Jun 15 2006 | OSIP | OSI PHARMACEUTICAL ... | LEUNG GABRIEL | Exec. VP, Pres., (O ... | Option Exercise | A | 29.77 | 20,000 | 595,400 | 20,000 |
Page: 1